Rationality of Cytoflavin Inclusion in the Treatment of Patients with Dermatological Pathology Comorbid with Mental Disorders

With the help of literature data, the effectiveness of Cytoflavin inclusion in the treatment regimens for patients with psoriasis, microbial eczema, and rosacea in the period of exacerbation was analyzed based on the assessment of subjective and objective data of the DLQI (Dermatology Life Quality Index), WAM (Well-being, Activity, Mood), DISS (Dermatological Index of the Symptom Scale). It was revealed that, according to the results of testing before the start of treatment, all patients had mental disorders, which manifested in an increase in indicators on the DLQI and DISS scales and a decrease on the WAM scale. The reduction of clinical manifestations and the decrease in DISS (by 86.0%, (P≤0.05) for rosacea, by 83.0% (P≤0.01) for eczema) was found to be more pronounced after a course of therapy with the inclusion of Cytoflavin (2 tablets 2 times a day 30 minutes before meals, course — 25 days), compared with standard therapy. This had a positive effect on well-being (the value of the indicator increased by 63,9% for rosacea, by 66,0% for eczema, and 27.8% for psoriasis), activity (56,1% for rosacea, 66.1 % for eczema, and 22.1% for psoriasis), mood (51,9% for rosacea, 54.3% for eczema, and 23.7% for psoriasis), and improved quality of life: indicator DLQI decreased by 42,9% in rosacea, 62.4% in eczema, and 61.5% in psoriasis. Thus, the analysis of literature data made it possible to confirm that the inclusion of Cytoflavin in the treatment regimens for patients with the above-mentioned skin pathologies, comorbid with mental disorders, improves the effectiveness of basic therapy, which is manifested by a faster and more pronounced reduction in clinical manifestations and an increase in the quality of life of patients.

1. Glazkova L.K., Volkova N.V. Nosogeny in dermatological practice: ways of correction Klinicheskaya Dermatologiya i Venerologiya. 2011; 4: 46–51(in Russian)

2. Karavaeva T.A., Korol'kova T.N. Psychological mechanisms and psychosomatic relationships in various dermatoses. Klinicheskaya Dermatologiya i Venerologiya. 2018; 17 (5): 7–16. https://doi.org/10.17116/klinderma2018170517. (in Russian)

3. Bao Q., Chen L., Lu Z., Ma Y., Guo L., Zhang S., Huang X., Xu S., Ruan L. Association between eczema and risk of depression: a systematic review and meta-analysis of 188,495 participants J Affect Disord. 2018 Oct 1; 238: 458–464. doi: 10.1016/j.jad.2018.05.007. Epub 2018 May 15.

4. Chang H.C., Huang Y.C., Lien Y.J., Chang Y.S. Association of rosacea with depression and anxiety: A systematic review and meta-analysis J Affect Disord. 2022 Feb 15; 299: 239–245. doi: 10.1016/j.jad.2021.12.008. Epub 2021 Dec 5.

5. González-Parra S., Daudén E. Psoriasis and depression: The Role of inflammation. Actas Dermosifiliogr (Engl Ed). 2019 Jan–Feb; 110 (1): 12–19. doi: 10.1016/j.ad.2018.05.009. Epub 2018 Dec 1.

6. Koo J., Marangell L.B., Nakamura M., Armstrong A., Jeon C., Bhutani T., Wu J.J. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol. 2017 Dec; 31 (12): 1999–2009. doi: 10.1111/jdv.14460. Epub 2017 Aug 9.

7. Heisig M., Reich A. Psychosocial aspects of rosacea with a focus on anxiety and depression. Clin Cosmet Investig Dermatol. 2018 Mar 6; 11: 103–107. doi: 10.2147/CCID.S126850. eCollection 2018.

8. Arslanova P.R., Zhiganov T.A., Sergeeva T.A. On the possibility of using vitamins in resistant depression. Ehksperimental'naya i Klinicheskaya Farmakologiya. 2021; 84 (4): 24–32. doi: https://doi.org/10.30906/0869-2092-2021-844-24-32. (in Russian)

9. Mazin P.V., SHeshunov I.V, Mazina N.K. Meta-analytical evaluation of the clinical efficacy of Cytoflavin in neurological diseases. Zhurnal Nevrologii i Psikhiatrii im. S. S. Korsakova. 2017; 3: 28–39. doi https://doi.org/10.17116/jnevro20171173128-39. (in Russian)

10. Dikova O.V., Tyukina T.A. Complex metabolic therapy in patients with psoriasis. Klinicheskaya Dermatologiya i Venerologiya. 2018; 17 (5): 59– 64. doi: https://doi.org/10.17116/klinderma20181705159. (in Russian)

11. Tyukina T.A., Dikova O.V., Shapovalova V.O. Dynamics of clinical symptoms of psoriasis under the influence of Cytoflavin. Medicus Dermatology. 2016; 8(2): 31–33. (in Russian)

12. Tyukina T.A., Dikova O.V., Shapovalova V.O. The effect of therapy with the use of Cytoflavin on the parameters of the psycho-emotional state of patients with psoriasis. Sovremennye Tendentsii Razvitiya Nauki i Tekhnologij. 2017; 1–3:122-124. (in Russian)

13. Laseev D.I., Dikova O.V., Laseeva M.G., Kovalenko A.L. Evaluation of the effectiveness of a drug with metabolic action in the complex therapy of eczema. Klinicheskaya Dermatologiya i Venerologiya. 2015; 2: 47–53. doi https://doi.org/10.17116/klinderma201514248-55. (in Russian)

14. Kotel'nikova M.A., Simonova N.V., Men'shhikova N.V., Shtarberg M.A. Results of the study of parameters of psycho-emotional and antioxidant status in patients with rosacea. Dal'nevostochnyj Meditsinskij Zhurnal. 2021; 4: 44–48. doi: https://doi.org/10.35177/19945191-2021-4-9. (in Russian)

15. Kotel'nikova M.A., Simonova N.V., Dorovskikh V.A., Shtarberg M.A. Effect of cytoflavin on the antioxidant status of patients with mild to moderate rosacea. Ehksperimental'naya i Klinicheskaya Farmakologiya. 2020; 83 (7): 32–37. doi: https://doi.org/10.30906/0869-2092-2020-83-7-32-37. (in Russian)